World Antimicrobial Awareness Week 2025
From Petri dishes to chips: what can microbiology learn from microfluidics?
Microfluidics is a fast-growing field focused on manipulating tiny volumes of fluid, often within channels no wider than a human hair. Despite its potential, around 90% of microbial experiments are still carried out under static conditions. So, what are we missing by ignoring flow? And how can microfluidics help close the gap?
Read story
Unlocking the secrets of phages: DNA modification discoveries offer new weapons against antimicrobial resistance
Bacteria and their viral predator bacteriophages (phages) have coevolved for billions of years and are engaged in an endless arms race against each other. DNA modifications are among the most widespread defenses to block bacterial RM and CRISPR-Cas systems.
Climate, conflict, and antimicrobial resistance: unravelling the threat to global health
Emerging evidence is revealing the interplay between AMR and climate change. How are they linked, and how can we address the challenge?
Parasitic worms: an unexplored source of novel antimicrobials?
Novel antimicrobials are desperately needed to combat the AMR crisis, however, the clinical and preclinical pipeline for novel antimicrobials is virtually stagnant. This article will shed light on parasitic worms as an unexplored and underappreciated source of antimicrobial peptides.
Top News in WAAW
AMI warns that the threat of antimicrobial resistance in viruses and other pathogens cannot be underestimated
Applied Microbiology International (AMI) has urged global policymakers to strengthen the revised Global Action Plan on Antimicrobial Resistance (GAP-AMR), calling for a more inclusive, clear and equitable approach to tackling one of the world’s most urgent health challenges.
Gut bacteria boost immune system and help send Vitamin A to T cells
Scientists have discovered that gut bacteria help regulate the development of the body’s immune system by directing the movement of vitamin A through a previously unrecognized cellular network.
Read story
Researchers use friendly viruses to tackle inflammatory bowel disease
A research team has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem.
Fighting the world’s deadliest infection with PAC-MAN and AI
Researchers have developed techniques that can speed up the search for better tuberculosis drugs. They first measure which chemical compounds are able to slip across the outer membrane and then use those measurements to predict other compounds that can get into the Mtb cell.
New HIV vaccine shows unprecedented success in preclinical study
Scientists have developed an HIV vaccine that trains immune cells to see past HIV’s defenses. This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies.
Why cruise ships remain vulnerable to viral outbreaks - and how new technologies could help
A dream holiday can quickly become a public health challenge when thousands of people share the same dining rooms, elevators and living spaces. Recent viral outbreaks on cruise ships have shown just how vulnerable these floating cities remain to infectious diseases.
Read story
Why chromogenic media matters when testing for invasive pathogens: Could the cheapest plate be an expensive decision?
Chris Armstrong, President of Microbiology, Thermo Fisher Scientific, argues that laboratories should stop judging fungal culture media on unit price alone.
The politics behind the global divide in bacteriophage therapy
The therapeutic potential of bacteriophages (or ‘phages’) has been widely dismissed for decades in the West, despite being regularly used to treat patients worldwide in the early and mid-20th century. In an age rife with disinformation, can the true potential of clinical phage technology be communicated to a public already uneasy about scientific intervention?
Could livestock-originated probiotics replace synthetic antibiotics for livestock?
In many developing countries, the use of antibiotics in both humans and animals is often indiscriminate and poorly regulated. Could livestock-originated probiotics be a suitable replacement?
Voice of the Future: Inspiring conversations at the science-policy interface
Earlier this year, Suparna Mitra and Alan Koh took part in the Royal Society of Biology’s Voice of the Future event at Parliament, representing AMI. Here they reflect on the experience and what they took away from it.
Read story
Q&A: Meet Letters in Applied Microbiology Junior Editor Daniel Jesuwenu Ajose
We caught up with Daniel Jesuwenu Ajose, a Postdoctoral Research Fellow at the School of Biology and Environmental Sciences, University of Mpumalanga in South Africa, who is one of the newest Junior Editors with Letters in Applied Microbiology.
Scientific Event Travel Grant: how the Safepork conference surpassed my expectations
Shan Goh from the University of Hertfordshire reports back on the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork held in Rennes, France, in October. Shan was supported with a Scientific Event Travel Grant awarded by AMI.
AMR in aquatic ecosystems: A One Health investigation in an irrigation dam in Thailand
Dr Kwanrawee Joy Sirikanchana outlines how her team has launched a major project to address an overlooked question: How much does aquaculture contribute to AMR in shared water systems, and what does this mean for people, animals, and wildlife living around them?